Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories

Systematic Review of Cases of Acute Myelitis in Individuals with COVID-19

COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction

Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine

Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination

Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19

Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection